A study to assess the safety, drug levels in blood and markers of immune system response in patients after multiple doses of a new compound developed for the treatment of cutaneous leishmaniasis, CpG-ODN-D35
http://isrctn.com/（2022）
关键词
cutaneous leishmaniasis,immune system response,immune system,multiple doses,drug levels,cpg-odn-d
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要